Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/8/26 17:11 | 7/6/26 | RLAY | Health | BioPrd | Biological Products, (No Diag | Bergstrom Donald A | MA | O | P,R,D | 8 | S.dm | -2,371 | 10.81 | 0 | -219 | 615 | D | |||||||||||||||
7/8/26 17:08 | 7/7/26 | RLAY | Health | BioPrd | Biological Products, (No Diag | Patel Sanjiv | MA | DO | P,CEO | 5 | S | -2,117 | 7.66 | 0 | -276 | 1,709 | D | |||||||||||||||
7/8/26 17:07 | 7/6/26 | RLAY | Health | BioPrd | Biological Products, (No Diag | Catinazzo Thomas | MA | O | CFO | 11 | S.dm | -4,610 | 13.48 | 0 | -342 | 375 | D | |||||||||||||||
7/2/26 16:12 | 6/30/26 | RLAY | Health | BioPrd | Biological Products, (No Diag | Rahmer Peter | MA | O | See rema | 7 | S.m | -1,466 | 10.96 | 0 | -134 | 402 | D | |||||||||||||||
7/30/25 16:53 | 7/28/25 | RLAY | Health | BioPrd | Biological Products, (No Diag | Adams Brian | MA | O | GC | 3 | S.m | -118 | 3.40 | 0 | -35 | 406 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |